메뉴 건너뛰기




Volumn 48, Issue 10, 2012, Pages 1364-1378

Exploiting nature’s rich source of proteasome inhibitors as starting points in drug development

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BORTEZOMIB; CARFILZOMIB; DELANZOMIB; FELLUTAMIDE B; FUNCTIONAL GROUP; GLIDOBACTIN A; HOMOBELACTOSIN C; LACTACYSTIN BETA LACTONE; NATURAL PRODUCT; PR 047; PR 957; PROTEASOME INHIBITOR; SALINOSPORAMIDE A; SYRINGOLIN A; TMC 86; TMC 89; TMC 95A; TMC 95B; TMC 95C; TMC 95D; TMC 96; UNCLASSIFIED DRUG;

EID: 84855663440     PISSN: 13597345     EISSN: 1364548X     Source Type: Journal    
DOI: 10.1039/c1cc15273d     Document Type: Article
Times cited : (54)

References (146)
  • 54
    • 0029033981 scopus 로고
    • G. Fenteany, Science, 1995, 268, 726-731
    • (1995) Science , vol.268 , pp. 726-731
    • Fenteany, G.1
  • 124
    • 33746002275 scopus 로고    scopus 로고
    • K. Nomura, Science, 2006, 313, 220-223
    • (2006) Science , vol.313 , pp. 220-223
    • Nomura, K.1
  • 128


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.